ACE2 and COVID-19: During the initial infection, COVID-19 mainly attacked the human immune system, resulting in “inflammatory storm,” in which new virus particles synthesized under the action of ACE2 were released to the outside of the cells, damaging the lung capillaries, and then resulting in the reduction of lung connexins and the enlargement of alveolar space.